PHASE-II TRIAL OF CISPLATIN IN ADVANCED OR RECURRENT CANCER OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：19
|
作者：
THIGPEN, JT
BLESSING, JA
HOMESLEY, HD
BEREK, JS
CREASMAN, WT
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED & OBSTET & GYNECOL,JACKSON,MS 39216
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,CANC RES SCI 5,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[3] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT OBSTET & GYNECOL,GYNECOL ONCOL SECT,WINSTON SALEM,NC 27103
[4] UNIV CALIF LOS ANGELES,SCH MED,DIV GYNECOL ONCOL,LOS ANGELES,CA 90024
[5] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
来源：
GYNECOLOGIC ONCOLOGY | 1986年 / 23卷 / 01期
关键词：
D O I：
10.1016/0090-8258(86)90121-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 104
页数：4
相关论文
共 50 条
  • [1] A PHASE-II TRIAL OF VINCRISTINE IN ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    BROUN, GO
    BLESSING, JA
    EDDY, GL
    ADELSON, MD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01): : 18 - 21
  • [2] PHASE-II TRIAL OF CISPLATIN IN THE TREATMENT OF PATIENTS WITH ADVANCED OR RECURRENT MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    ORR, JW
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 271 - 274
  • [3] PHASE-II TRIAL OF ADRIAMYCIN IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BUCHSBAUM, HJ
    MANGAN, C
    BLESSING, JA
    CANCER TREATMENT REPORTS, 1979, 63 (01): : 21 - 27
  • [4] PHASE-II TRIAL OF CISPLATIN AS 2-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    LAGASSE, LD
    DISAIA, PJ
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 253 - 256
  • [5] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA AND CARCINOMA OF THE VAGINA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    BEECHAM, J
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 869 - 870
  • [6] PHASE-II TRIAL OF RAZOXANE IN THE MANAGEMENT OF RECURRENT ADENOCARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    CONROY, JF
    BLESSING, JA
    KESSINGER, A
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (02): : 439 - 440
  • [7] PHASE-II TRIAL OF CISPLATIN AS 1ST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT UTERINE SARCOMAS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    BEECHAM, J
    HOMESLEY, H
    YORDAN, E
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) : 1962 - 1966
  • [8] PHASE-II TRIAL OF CISPLATIN AS 1ST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, H
    CREASMAN, WT
    SUTTON, G
    GYNECOLOGIC ONCOLOGY, 1989, 33 (01) : 68 - 70
  • [9] PHASE-II STUDY OF MAYTANSINE IN THE TREATMENT OF ADVANCED OR RECURRENT ADENOCARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    EHRLICH, CE
    CREASMAN, WT
    CURRY, S
    BLESSING, JA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (03): : 273 - 275
  • [10] PHASE-II TRIAL OF VINBLASTINE IN ADVANCED OVARIAN-CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    ADELSON, MD
    HANJANI, P
    INVESTIGATIONAL NEW DRUGS, 1990, 8 (04) : 377 - 379
12345